Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 21, 2022 - Issue 3
Submit an article Journal homepage
1,069
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflections

Ali A. Rizvia Department of Medicine, University of Central Florida College of Medicine, Orlando, FL, USA;b Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of South Carolina, Columbia, SC, USAORCID Iconhttps://orcid.org/0000-0002-3714-0790
ORCID Icon,
Ales Linhartc Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
,
Michal Vrablikd Third Department of Internal Medicine, General University Hospital and First Medical Faculty, Charles University, Prague, Czech Republic
,
Evangelos Liberopoulose First Propedeutic Department of Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
&
Manfredi Rizzob Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of South Carolina, Columbia, SC, USA;f Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (Promise), School of Medicine, University of Palermo, Palermo, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9549-8504
ORCID Icon
Pages 291-293 | Received 18 Nov 2021, Accepted 10 Jan 2022, Published online: 25 Feb 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dimitrios Patoulias, Massimiliano Caprio, Anca Pantea Stoian & Manfredi Rizzo. (2023) Tirzepatide and glucagon-like peptide-1 receptor agonists: safety always comes first!. Expert Opinion on Drug Safety 22:9, pages 763-765.
Read now

Articles from other publishers (3)

Virginie Blanchette, David G. Armstrong, Laura Drudi & Manfredi Rizzo. (2023) Upstream comprehensive management of individuals with diabetes with multimorbidity and frailty to act against amputation. Journal of Diabetes and its Complications 37:3, pages 108407.
Crossref
Rosaria Vincenza Giglio, Angelo Maria Patti, Ali Abbas Rizvi, Anca Panta Stoian, Marcello Ciaccio, Nikolaos Papanas, Andrej Janez, Alper Sonmez, Maciej Banach, Amirhossein Sahebkar & Manfredi Rizzo. (2023) Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update. Biomedicines 11:2, pages 291.
Crossref
Rosaria Vincenza Giglio, Nikolaos Papanas, Ali Abbas Rizvi, Marcello Ciaccio, Angelo Maria Patti, Ioannis Ilias, Anca Pantea Stoian, Amirhossein Sahebkar, Andrej Janez & Manfredi Rizzo. (2022) An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes. Medicina 58:10, pages 1475.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.